Skip to main content

Table 3 Effect of tamsulosin only on group A

From: The impact of adding solifenacin to tamsulosin therapy for treatment of storage lower urinary tract symptoms owing to benign prostatic hyperplasia

P-value After (mean ± SD) Before (mean ± SD)  
< 0.001 2.30 ± 0.50 4.36 ± 0.52 (1) Quality of life
< 0.001* 7.87 ± 1.555 11.63 ± 1.475 (2) OABSS
  1. Asterisk represents significant difference between both groups: P value < 0.05 was considered statistically significant